Cure My Disease

Don't miss your cure!

 Log in / Sign up

20,000 volunteers test if educational videos boost heart risk awareness

NCT ID NCT07177612

Knowledge-focused Sponsor: Changi General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This observational study enrolls 20,000 people aged 16 and older to see if short educational videos about the LILAC method can improve knowledge and management of elevated lipoprotein(a), a genetic risk factor for heart disease. Participants will complete surveys to measure awareness and confidence, and doctors will report whether they test for Lp(a) before and after watching the videos. The goal is to assess feasibility and acceptance, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 20,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study populations include healthcare professionals, patients, and members of the public.

Ages

16 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants include students, participants from institute of higher learning aged 16 and above. * Participants aged 16 and above regardless of local or overseas, may also be from educational talks that Dr Loh is invited to speak at. * Patients and members of the public aged 16 and above if they attend lipid awareness educational events. * Participants aged 16 and above in patient support groups or patient advocacy networks. Exclusion Criteria: * Participants aged below 16 years old.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lipoprotein(A) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperlipoproteinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lipoprotein(A) Lipoprotein(A), hyper-LP(A)-emia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Changi General Hospital

    Singapore, Singapore

  • Online Portal, Australia

    Perth, Australia

  • Online web portal

    Kuala Lumpur, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.